Literature DB >> 25378652

Proceedings: debilitating eye diseases.

Ingrid W Caras1, Neil Littman2, Arie Abo2.   

Abstract

Debilitating eye diseases such as age-related macular degeneration and retinitis pigmentosa currently represent a large unmet medical need that could potentially be addressed by stem cell therapy. A number of novel stem cell-based cellular therapies are now under development to treat a variety of eye diseases. The approaches being taken by the California Institute for Regenerative Medicine, together with its grantees, are discussed. ©AlphaMed Press.

Entities:  

Mesh：

Year:  2014        PMID： 25378652      PMCID： PMC4250220          DOI： 10.5966/sctm.2014-0221

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN： 2157-6564            Impact factor:   6.940


  6 in total

1.  A three-dimensional culture method to expand limbal stem/progenitor cells.

Authors:  Hua Mei; Sheyla González; Martin N Nakatsu; Elfren Ray Baclagon; Vanda S Lopes; David S Williams; Sophie X Deng
Journal:  Tissue Eng Part C Methods       Date:  2013-11-07       Impact factor: 3.056

2.  Eyes on the prize: limbal stem cells and corneal restoration.

Authors:  Graziella Pellegrini; Michele De Luca
Journal:  Cell Stem Cell       Date:  2014-08-07       Impact factor: 24.633

3.  Retinal stem cells and potential cell transplantation treatments.

Authors:  Tai-Chi Lin; Chih-Chien Hsu; Ke-Hung Chien; Kuo-Hsuan Hung; Chi-Hsien Peng; Shih-Jen Chen
Journal:  J Chin Med Assoc       Date:  2014-09-18       Impact factor: 2.743

4.  Limbal stem-cell therapy and long-term corneal regeneration.

Authors:  Paolo Rama; Stanislav Matuska; Giorgio Paganoni; Alessandra Spinelli; Michele De Luca; Graziella Pellegrini
Journal:  N Engl J Med       Date:  2010-06-23       Impact factor: 91.245

5.  One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration.

Authors:  A Abdel-Meguid; A Lappas; K Hartmann; F Auer; N Schrage; G Thumann; B Kirchhof
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

6.  Prevalence of age-related macular degeneration in the United States.

Authors:  David S Friedman; Benita J O'Colmain; Beatriz Muñoz; Sandra C Tomany; Cathy McCarty; Paulus T V M de Jong; Barbara Nemesure; Paul Mitchell; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04
  6 in total
  2 in total

Review 1.  Let There Be Light: Gene and Cell Therapy for Blindness.

Authors:  Deniz Dalkara; Olivier Goureau; Katia Marazova; José-Alain Sahel
Journal:  Hum Gene Ther       Date:  2016-02       Impact factor: 5.695

Review 2.  Current status of pluripotent stem cells: moving the first therapies to the clinic.

Authors:  Erin A Kimbrel; Robert Lanza
Journal:  Nat Rev Drug Discov       Date:  2015-09-22       Impact factor: 84.694
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.